Copyright
©The Author(s) 2020.
World J Gastroenterol. Dec 21, 2020; 26(47): 7444-7469
Published online Dec 21, 2020. doi: 10.3748/wjg.v26.i47.7444
Published online Dec 21, 2020. doi: 10.3748/wjg.v26.i47.7444
Figure 5 Potential contributions of bone marrow-derived mesenchymal stem cells to liver fibrosis.
Each of the presented elements represent a distinct mechanism that has a specific role that can contribute to alleviating liver fibrosis. BM-MSCs: Bone marrow-derived mesenchymal stem cells; HSCs: Hepatic stellate cells; KC: Kupffer cells.
- Citation: Al-Dhamin Z, Liu LD, Li DD, Zhang SY, Dong SM, Nan YM. Therapeutic efficiency of bone marrow-derived mesenchymal stem cells for liver fibrosis: A systematic review of in vivo studies. World J Gastroenterol 2020; 26(47): 7444-7469
- URL: https://www.wjgnet.com/1007-9327/full/v26/i47/7444.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i47.7444